Gut microbiota metabolite trimethylamine N-oxide promoted NAFLD progression by exacerbating intestinal barrier disruption and intrahepatic cellular imbalance
January 2026 saw the gap narrow, however, as the Medicines and Healthcare products Regulatory Agency (MHRA) approved a new, higher Wegovy 7.2 mg dose that could offer greater weight loss potential than before
This powerhouse combination collaborates to effectively combat dark spots, hyperpigmentation, and uneven skin tone, promising a visibly brighter complexion with consistent use
From Parkinsons and kidney disease to chemical dependency and sleep apnea, researchers are finding promise in the GLP-1 drugs treating a wide array of conditions
Richie, professor of Public Health Sciences and Pharmacology at Penn State University College of Medicine in Hershey, has studied glutathione for over 30 years